Catalyst Pharmaceuticals logo
Catalyst Pharmaceuticals CPRX
€ 21.13 2.47%

Quartalsbericht 2024-Q3
hinzugefügt 06.11.2024

report update icon

Catalyst Pharmaceuticals Kennzahlen 2011-2024 | CPRX

Kennzahlen Jährlich Catalyst Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

21.9 17.8 15.1 5.0 13.5 -7.5 -16.2 -5.0 -7.4 -15.1 -7.4 -4.0 -3.7

P/S

3.9 6.9 4.2 3.2 4.2 507.0 - - - - - - -

EPS

0.7 0.8 0.4 0.7 0.3 -0.3 -0.2 -0.2 -0.2 -0.2 -0.3 -0.1 -0.3

EV (Enterprise Value)

1.51 B 1.25 B 455 M 269 M 367 M 247 M 246 M 78.8 M 127 M 234 M 92.2 M 17 M 20.1 M

EBITDA per Share

0.82 0.99 0.51 0.4 0.312 -0.344 -0.217 -0.232 -0.252 -0.227 -0.226 -0.173 -0.278

EV/EBITDA

7.2 5.9 10.6 -6.7 -12.9 -4.0 -6.0 -15.4 -8.6 -2.8 -2.9

PEG

-1.88 5.18 -0.9 -0.21 0.07 0.13 -3.57 -0.42 1.78 -1.36 0.08 -0.08 0.12

P/B

4.0 4.9 2.9 2.2 4.9 5.0 3.7 2.3 2.7 6.6 4.2 1.1 6.3

P/CF

10.9 12.7 9.9 8.4 12.5 -9.8 -21.7 -5.0 -8.3 -18.0 -9.2 -3.1 -4.7

ROE %

18.41 27.65 19.09 44.21 36.37 -66.96 -22.74 -45.98 -36.47 -44.01 -56.82 -27.88 -169.94

ROA %

15.19 22.12 16.60 38.98 28.36 -56.25 -21.56 -43.33 -33.66 -35.32 -47.91 -24.28 -102.27

ROCE %

22.38 33.90 25.33 24.35 36.05 -69.29 -23.03 -48.67 -36.00 -38.34 -44.39 -34.48 -112.31

Current Ratio

5.7 5.0 7.7 8.5 4.6 5.8 20.0 19.8 17.4 7.5 11.8 10.2 7.5

DSO

29.3 14.5 16.3 25.3 37.6 - - - - - - - -

DIO

78.8 77.9 104.4 70.8 48.4 - - - - - - - -

DPO

65.9 35.8 58.6 89.7 101.8 - - - - - - - -

Betriebszyklus

108.2 92.4 120.8 96.1 86.0 - - - - - - - -

Finanzkreislauf

42.2 56.6 62.2 6.4 -15.8 - - - - - - - -

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich Catalyst Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

0.37 0.35 0.2 - -0.29 0.36 0.28 - 0.22 0.21 0.13 - 0.1 0.12 0.07 - 0.42 0.09 0.1 0.08 0.13 0.11 -0.01 -0.14 -0.08 -0.06 -0.06 -0.06 -0.05 -0.05 -0.06 -0.05 -0.05 -0.06 -0.07 -0.07 -0.05 -0.06 -0.07 -0.05 -0.07 -0.05 -0.07 -0.03 -0.13 -0.08 -0.04 - -0.08 -0.01 -0.04 -0.1 -0.05 -0.06 -0.08

EBITDA per Share

- - 0.23 - - - 0.34 - 0.24 0.28 0.17 - 0.14 0.15 0.1 - 0.11 0.1 0.1 0.08 0.13 0.11 -0.01 -0.14 -0.08 -0.06 -0.06 -0.05 -0.05 -0.05 -0.06 -0.05 -0.05 -0.06 -0.08 -0.07 -0.06 -0.06 -0.06 -0.06 -0.06 -0.05 -0.06 -0.05 -0.07 -0.06 -0.04 -0.04 -0.04 -0.04 -0.06 -0.08 -0.05 -0.06 -0.06

ROE %

8.66 -6.80 -3.44 10.10 18.52 35.77 34.68 23.40 28.60 25.38 22.86 15.94 41.49 61.85 61.17 37.47 46.52 36.52 43.26 36.37 -1.23 -32.22 -56.47 -66.96 -45.06 -34.78 -27.83 -22.74 -26.68 -31.58 -38.41 -45.98 -45.87 -43.83 -40.42 -36.47 -35.89 -42.09 -42.95 -44.01 -40.44 -53.86 -59.48 -56.82 -51.01 -41.30 -28.58 -27.88 -89.89 -101.96 -137.05 -169.94 -29.99 -37.07 -40.34

ROA %

7.61 -5.52 -2.78 8.32 15.15 29.43 29.01 20.28 24.90 22.70 20.44 14.34 36.87 54.77 54.03 33.04 40.09 29.69 34.36 28.36 -2.68 -27.77 -47.40 -56.25 -38.57 -30.50 -25.18 -21.56 -25.24 -29.82 -36.23 -43.33 -43.03 -40.95 -37.58 -33.66 -31.94 -35.94 -35.64 -35.32 -32.71 -44.61 -49.71 -47.91 -43.03 -35.34 -24.67 -24.28 -61.46 -63.89 -84.48 -102.27 -18.05 -22.31 -24.28

ROCE %

10.78 -7.59 -4.06 12.45 21.74 41.71 41.11 29.03 36.08 33.83 30.37 20.92 27.82 27.67 25.35 19.27 28.41 37.31 43.75 36.32 -2.05 -33.96 -58.94 -69.50 -47.08 -36.29 -28.98 -23.07 -27.24 -31.88 -38.96 -49.05 -49.23 -48.32 -44.90 -36.77 -36.91 -39.53 -39.18 -41.40 -42.75 -46.27 -50.19 -48.21 -45.85 -39.45 -34.35 -35.71 -79.51 -100.80 -130.66 -161.73 -30.07 -37.16 -40.40

Current Ratio

7.0 7.2 7.6 5.7 6.4 6.5 5.5 5.0 5.3 10.2 9.2 7.7 9.1 10.4 10.6 8.4 8.4 8.4 8.4 4.5 4.5 4.5 4.5 6.2 6.2 6.2 6.2 19.3 19.3 19.3 19.3 17.4 17.4 17.4 17.4 13.0 13.0 13.0 13.0 5.1 5.1 5.1 5.1 6.4 6.4 6.4 6.4 7.8 7.8 7.8 7.8 2.5 2.5 2.5 2.5

DSO

40.9 43.8 52.8 - 40.4 34.9 23.4 - 15.1 17.3 18.2 - 16.4 14.9 17.5 - 18.6 18.4 25.9 31.9 31.1 33.3 38.6 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

90.0 112.5 129.7 - 63.7 79.8 78.6 - 70.7 93.6 121.6 - 120.7 115.3 88.1 - 109.4 102.5 72.6 - 40.7 41.9 53.6 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

44.2 51.5 91.3 - 29.1 29.6 33.8 - 22.9 44.5 61.2 - 48.8 55.1 66.4 - 100.1 93.8 92.0 - 85.6 88.2 172.0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

130.9 156.2 182.5 - 104.1 114.8 102.0 - 85.8 110.9 139.8 - 137.1 130.2 105.6 - 128.0 121.0 98.5 31.9 71.8 75.2 92.3 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Finanzkreislauf

86.7 104.7 91.2 - 75.0 85.2 68.2 - 62.9 66.4 78.5 - 88.3 75.2 39.2 - 27.9 27.1 6.5 31.9 -13.8 -12.9 -79.8 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung